CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Dec. 9, 2021—Roche announced the launch of three research use only automated digital pathology algorithms, uPath Ki-67 (30-9), uPath ER (SP1), and uPath PR (1E2) image analysis for breast cancer.
uPath Ki-67 (30-9) image analysis, uPath ER (SP1) image analysis, and uPath PR (1E2) image analysis for breast cancer use pathologist-trained deep learning algorithms to enable quick calculation of Ki-67, ER, and PR tumor cell nuclei positivity. This includes a whole slide analysis workflow with automated pre-computing of the slide image prior to pathologist assessment and a clear visual overlay highlighting tumor cells with and without nuclear staining.
Pages: 1 2